Mérieux Equity Partners
France · 54 portfolio companies
· first tracked 20 June 2026
Portfolio
| Company | Sector | Stage | Country |
|---|
| AcuSurgical |
Medtech | Series A | |
| Advencis |
Biotech, Medtech | | |
| Amplitude Systèmes |
Biotech, Medtech | | |
| Amyl Therapeutics |
Biotech | Series A | |
| Biobest |
Healthtech | | |
| Broken String Biosciences |
Biotech | Series A | |
| CEVA Santé Animale |
Agritech | | France |
| Cairdac |
Medtech | Series A | |
| Cell-Easy |
Biotech | Series A | |
| Corflow |
Medtech | | |
| Curea Medical GmbH |
Medtech | | |
| DOC Generici |
Biotech | | |
| Deepull |
Medtech | Series B | |
| Dental Monitoring |
Healthtech | | France |
| Domus VI |
Healthtech | | France |
| Elsan |
Healthtech | | |
| GTP Bioways |
Biotech | | |
| Health in Code |
Biotech, Medtech | | |
| InnoSyn |
Biotech | | |
| Inscripta |
Biotech | Series E | United States |
| Ivantis |
Medtech | | United States |
| Janvier Labs |
Biotech | | |
| Kalila Medical |
Biotech | | United States |
| KeepMED |
Medtech | Series C | |
| Keranova |
Medtech | Series B | |
| LNA Santé |
Healthtech | | France |
| LabQuality |
Biotech | | |
| Laboratoires INELDEA |
Healthtech | | |
| Lavorel Medicare |
Healthtech | | |
| MRM Health |
Biotech | Series B | |
| Mablink Bioscience |
Biotech | Series A | France |
| Mabtech |
Biotech, Medtech | | |
| Mimetas |
Biotech | Series B | |
| Neurinnov |
Medtech | Seed | |
| Nutragroup |
Healthtech | | |
| Ona Therapeutics |
Biotech | Series B | |
| Origene |
Biotech, Medtech | | United States |
| Physioassist |
Medtech | Series B | |
| Piercan |
Biotech | | France |
| Plantex |
Healthtech | | |
| Prodigest |
Biotech | Series A | |
| Prothea Technologies |
Biotech, Medtech | | |
| Quantalife |
Biotech | | |
| SERB Pharmaceuticals |
Biotech | | |
| SGH Medical Pharma |
Biotech, Medtech | | |
| SWIXX BioPharma |
Biotech | | |
| SeqOne Genomics |
Healthtech, Medtech, Biotech | Series A | France |
| Seqens |
Biotech | | |
| Supersonic Imagine |
Medtech, Biotech | | France |
| TARA Biosystems |
Biotech | Series A | United States |
| TWIST Bioscience |
Biotech | | United States |
| Theravia |
Biotech | | |
| Triple Ring Technologies |
Biotech | | United States |
| XERIS Pharmaceuticals |
Biotech | IPO | United States |
Recorded changes
- 20 June 2026 Deepull's stage changed from Seed to Series B (Mérieux Equity Partners)